secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mereo BioPharma Group plc (MREO)
CIK:        0001719714
Form:       8-K
Filed at:   2024-04-15T23:59:59+00:00
Accession:  0001193125-24-095508
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mereo BioPharma extends cooperation with Rubric Capital; Justin Roberts to remain on board through 2025 AGM
--------------------------------------------------------------------------------

- Extension letter dated April 15, 2024 waives resignation requirement for director Justin Roberts after 2024 AGM.
- Termination date of Cooperation Agreement extended to immediately after the 2025 annual shareholder meeting.
- Cooperation Agreement originally dated October 28, 2022 between Mereo and Rubric Capital Management L.P.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719714/000119312524095508/0001193125-24-095508-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719714/000119312524095508/d818381d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-095508

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer